I disagree. I think there is a near 100% certainty that FY2009 will be cash flow positive, without factoring in the minimal BARDA revenues. BARDA is very important to the company, but not for the minimal revenues it generates. It is important for the huge costs it covers, and for the scientific data it generates.
- Forums
- ASX - By Stock
- PNV
- Polynovo’s Novosorb is a med-tech Swiss Army Knife
PNV
polynovo limited
Add to My Watchlist
3.28%
!
$1.26

Polynovo’s Novosorb is a med-tech Swiss Army Knife, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.26 |
Change
0.040(3.28%) |
Mkt cap ! $870.4M |
Open | High | Low | Value | Volume |
$1.22 | $1.27 | $1.20 | $6.262M | 4.992M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 22000 | $1.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.27 | 4560 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.250 |
1 | 1500 | 1.245 |
1 | 500 | 1.220 |
6 | 41667 | 1.200 |
1 | 21000 | 1.195 |
Price($) | Vol. | No. |
---|---|---|
1.265 | 4560 | 2 |
1.275 | 14318 | 2 |
1.280 | 594 | 2 |
1.285 | 3990 | 1 |
1.290 | 15355 | 3 |
Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |